Genetic screening for multiple polymorphisms in Jordanian cardiovascular disease patients has been studied for multiple genes that are reported with warfarin responsiveness [31–34], however there is no record of studies that corelate MEF2A and SLC22A3-LPAL2-LPA with warfarin responsiveness in Jordanian cardiovascular disease patients. The gene discussed is LPAL2; the disease is cardiovascular disorder.